Evidence map›Paper›PMID 33200379›Full record

ArticleMolecular and cellular biochemistry2021

Computational study of pomegranate peel extract polyphenols as potential inhibitors of SARS-CoV-2 virus internalization.

Relja Suručić, Biljana Tubić, Miloš P Stojiljković, Dragan M Djuric, Maja Travar, Milkica Grabež, Katarina Šavikin, Ranko Škrbić

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biochemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. The Effect of Pomegranate Tea on the Clinical Outcomes and Symptom Alleviation in COVID-19 Patients: A Double-Blind Randomized Clinical Trial.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Pomegranate: A review of the heavenly healer's past, present, and future.Iranian journal of basic medical sciences · 2023
    Review
  14. Willow (Frontiers in microbiology · 2023
    Article
  15. Article
  16. Antiviral activity of medicinal plant-derived products against SARS-CoV-2.Experimental biology and medicine (Maywood, N.J.) · 2022
    Review
  17. Review
  18. Article
  19. In Silico and In Vitro Studies ofMolecules (Basel, Switzerland) · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Relja SuručićDepartment of Pharmacognosy, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina.
Biljana TubićDepartment of Pharmaceutical chemistry, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina.
Miloš P StojiljkovićDepartment of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina.
Dragan M DjuricInstitute of Medical Physiology "Richard Burian", Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Maja TravarDepartment of Microbiology, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina.
Milkica GrabežDepartment of Hygiene, Public Health Institute of Republic of Srpska, Banja Luka, Bosnia and Herzegovina.
Katarina ŠavikinInstitute for Medicinal Plant Research "Dr Josif Pančić", Belgrade, Serbia.
Ranko ŠkrbićDepartment of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina. ranko.skrbic@med.unibl.org.ORCID http://orcid.org/0000-0002-6643-1781
University of Banja Luka · BAInstitute for Plant Protection and Environment · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The search for effective coronavirus disease (COVID-19) therapy has attracted a great deal of scientific interest due to its unprecedented health care system overload worldwide. We have carried out a study to investigate the in silico effects of the most abundant pomegranate peel extract constituents on the multi-step process of serious acute respiratory syndrome coronavirus 2 (SARS-CoV-2) internalization in the host cells. Binding affinities and interactions of ellagic acid, gallic acid, punicalagin and punicalin were studied on four selected protein targets with a significant and confirmed role in the process of the entry of virus into a host cell. The protein targets used in this study were: SARS-CoV-2 spike glycoprotein, angiotensin-converting enzyme 2, furin and transmembrane serine protease 2. The results showed that the constituents of pomegranate peel extracts, namely punicalagin and punicalin had very promising potential for significant interactions with the selected protein targets and were therefore deemed good candidates for further in vitro and in vivo evaluation.

Indexed as

COVID-19 Drug TreatmentComputational BiologyCOVID-19HumansPlant ExtractsPolyphenolsPomegranateProtein BindingProtein DomainsSARS-CoV-2Spike Glycoprotein, CoronavirusVirus InternalizationPlant ExtractsPolyphenolsSpike Glycoprotein, Coronavirusspike glycoprotein, SARS-CoVCOVID-19Molecular dockingPomegranate peel extractPunicalaginPunicalinSARS-CoV-2

Identifiers

PMID33200379
PMCPMC7668668
OpenAlexW3102609266

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.